Owlet publishes investor deck outlining pediatric health platform, $106M revenue and subscription growth

Owlet, Inc. Class A

Owlet, Inc. Class A

OWLT

0.00
  • Owlet outlined strategy to expand from infant monitoring into broader pediatric health platform, with recurring revenue focus.
  • FY 2025 revenue reported at USD 106 million, with 35% year-on-year growth.
  • Active users reached 650,000+ in 2025.
  • Owlet360 subscription service reached 115,000+ paying subscribers, with 25%+ attach rate at USD 9.99 monthly.
  • Presentation highlighted Dream Sock as first and only FDA-cleared over-the-counter pediatric health monitor, positioning clearance as barrier to entry.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Owlet Inc. published the original content used to generate this news brief on April 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.